The United States begins administering the Pfizer–BioNTech COVID-19 vaccine to children between ages of 5 and 11 years old nationwide. 2021-11-3
Australia expands eligibility for the Pfizer–BioNTech and Moderna COVID-19 vaccines to include seniors over the age of 60 who had previously only been eligible for the Oxford–AstraZeneca vaccine. 2021-10-1
The Food and Drug Administration officially authorizes the usage of a third dosage of the Pfizer–BioNTech COVID-19 vaccine as a booster shot for individuals still considered vulnerable to COVID-19. Among those eligible are health care workers and senior citizens who have been fully inoculated with the vaccine for at least six months. 2021-09-22
Pfizer says that their vaccine candidate is effective for children between the ages of 5 and 11 years. 2021-09-20
The U.S. Food and Drug Administration authorizes a booster dose of the Pfizer–BioNTech and Moderna COVID-19 vaccines for immunocompromised people. 2021-08-12
The Biden administration announces that the United States has purchased 200 million extra doses of the vaccine developed by Pfizer and BioNTech, including doses intended for children under the age of 12 years old. 2021-07-23
Pfizer says that they plan to develop new vaccines for other viruses following the success of their COVID-19 vaccine candidate. 2021-03-23
Lab studies suggest that the Pfizer–BioNTech and Moderna COVID-19 vaccines are significantly less effective in providing antibody protection against the 501.V2 variant of the disease, which is most prevalent in South Africa. 2021-02-18
The Israeli Maccabi Healthcare Services confirm that, in a trial of 602,000 people who received the Pfizer-BioNTech vaccine, the vaccine's effectiveness was 95%. 2021-02-17
Israeli Prime Minister Benjamin Netanyahu became the first person in Israel to receive the vaccine made by Pfizer and BioNTech and getting the shot on live television. 2020-12-19